These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10851870)

  • 1. [Insulin and oral antidiabetic drugs. How to combine them in type 2 diabetes?].
    Lotz N
    MMW Fortschr Med; 2000 May; 142(18):45-8. PubMed ID: 10851870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin or insulin + oral hypoglycemic drugs in the treatment of type 2 diabetes difficult to compensate metabolically?].
    Carta Q; Trovati M; Dani F; Caselle MT; Vitali S; Cavalot F; Rocca G; Cantino G; Mularoni E; Libertucci D
    Minerva Endocrinol; 1984; 9(2):241-5. PubMed ID: 6390138
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA; Palumbo PJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inadequate blood glucose control with oral antidiabetic drugs. Early conversion to insulin].
    MMW Fortschr Med; 2002 Jul; 144(27-28):61. PubMed ID: 12198890
    [No Abstract]   [Full Text] [Related]  

  • 5. Addition of insulin to oral therapy in type 2 diabetes.
    Dağdelen S
    N Engl J Med; 2008 Mar; 358(11):1197; author reply 1198. PubMed ID: 18337612
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
    Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y
    Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
    [No Abstract]   [Full Text] [Related]  

  • 8. [When oral antidiabetics are no longer enough. Tablets plus basal insulin].
    Meissner T
    MMW Fortschr Med; 2001 Aug; 143(31-32):46. PubMed ID: 11556193
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy in NIDDM.
    Raskin P
    N Engl J Med; 1992 Nov; 327(20):1453-4. PubMed ID: 1406863
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic strategies in type 2 diabetes].
    Waeber G; Vollenweider P; Ruiz J
    Praxis (Bern 1994); 2001 Dec; 90(51-52):2245-54. PubMed ID: 11820166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
    Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.
    Howlett H; Porte F; Allavoine T; Kuhn T; Nicholson G
    Curr Med Res Opin; 2003; 19(3):218-25. PubMed ID: 12803736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.
    Yang WY; Ji QH; Zhu DL; Yang JK; Chen LL; Liu ZM; Yu DM; Yan L
    Chin Med J (Engl); 2009 Jul; 122(14):1704-8. PubMed ID: 19719975
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin therapy in type 2 diabetes.
    Wyne KL; Mora PF
    Endocr Res; 2007; 32(3):71-107. PubMed ID: 18092196
    [No Abstract]   [Full Text] [Related]  

  • 15. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early control of diabetic sequelae. Combined insulin treatment also in type 2].
    MMW Fortschr Med; 2000 Jun; 142(25):57. PubMed ID: 10920674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral antidiabetic drugs in 2003].
    Ducobu J
    Rev Med Brux; 2003 Sep; 24(4):A361-8. PubMed ID: 14606302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
    Winkler G; Baranyi E
    Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.